Nanopore Metagenomic Sequencing for Detection and Characterization of SARS-CoV-2 in Clinical Samples
Nick P.G. Gauthier, Cassidy Nelson, Michael B. Bonsall, Kerstin Locher, Marthe Charles, Clayton MacDonald, Mel Krajden, View ORCID ProfileSamuel D. Chorlton, Amee R. Manges
doi: https://doi.org/10.1101/2021.08.13.21261922
Nick P.G. Gauthier
1Department of Microbiology and Immunology, University of British Columbia, Vancouver, British Columbia, Canada
Cassidy Nelson
2Mathematical Ecology Research Group, Department of Zoology, University of Oxford, Oxford, United Kingdom
Michael B. Bonsall
2Mathematical Ecology Research Group, Department of Zoology, University of Oxford, Oxford, United Kingdom
Kerstin Locher
3Division of Medical Microbiology, Vancouver General Hospital, Vancouver, British Columbia, Canada
4Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada
Marthe Charles
3Division of Medical Microbiology, Vancouver General Hospital, Vancouver, British Columbia, Canada
4Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada
Clayton MacDonald
3Division of Medical Microbiology, Vancouver General Hospital, Vancouver, British Columbia, Canada
4Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada
Mel Krajden
4Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada
5British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada
Samuel D. Chorlton
4Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada
6BugSeq Bioinformatics Inc, Vancouver, British Columbia, Canada
Amee R. Manges
5British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada
7School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada
Article usage
Posted August 23, 2021.
Nanopore Metagenomic Sequencing for Detection and Characterization of SARS-CoV-2 in Clinical Samples
Nick P.G. Gauthier, Cassidy Nelson, Michael B. Bonsall, Kerstin Locher, Marthe Charles, Clayton MacDonald, Mel Krajden, Samuel D. Chorlton, Amee R. Manges
medRxiv 2021.08.13.21261922; doi: https://doi.org/10.1101/2021.08.13.21261922
Nanopore Metagenomic Sequencing for Detection and Characterization of SARS-CoV-2 in Clinical Samples
Nick P.G. Gauthier, Cassidy Nelson, Michael B. Bonsall, Kerstin Locher, Marthe Charles, Clayton MacDonald, Mel Krajden, Samuel D. Chorlton, Amee R. Manges
medRxiv 2021.08.13.21261922; doi: https://doi.org/10.1101/2021.08.13.21261922
Subject Area
Subject Areas
- Addiction Medicine (383)
- Allergy and Immunology (699)
- Anesthesia (192)
- Cardiovascular Medicine (2852)
- Dermatology (244)
- Emergency Medicine (430)
- Epidemiology (12560)
- Forensic Medicine (10)
- Gastroenterology (806)
- Genetic and Genomic Medicine (4434)
- Geriatric Medicine (401)
- Health Economics (716)
- Health Informatics (2850)
- Health Policy (1048)
- Hematology (375)
- HIV/AIDS (893)
- Medical Education (413)
- Medical Ethics (114)
- Nephrology (462)
- Neurology (4193)
- Nursing (222)
- Nutrition (617)
- Oncology (2204)
- Ophthalmology (624)
- Orthopedics (254)
- Otolaryngology (318)
- Pain Medicine (268)
- Palliative Medicine (82)
- Pathology (486)
- Pediatrics (1171)
- Primary Care Research (483)
- Public and Global Health (6782)
- Radiology and Imaging (1490)
- Respiratory Medicine (900)
- Rheumatology (430)
- Sports Medicine (369)
- Surgery (473)
- Toxicology (57)
- Transplantation (201)
- Urology (174)